914201-24-4

Basic information

• Product Name: 8-nitro-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one
• Synonyms: 8-nitro-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one
• CAS NO: 914201-24-4
• Molecular Formula: C10H10N2O3
• Molecular Weight: 206.2
• Mol File: 914201-24-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 8-nitro-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 8-nitro-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one(914201-24-4)
• EPA Substance Registry System: 8-nitro-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one(914201-24-4)

Safety Data

• Hazardous Substances Data: 914201-24-4(Hazardous Substances Data)

Upstream product

• 40353-34-2 7-nitro-3,4-dihydro-2H-naphthalen-1-one 
• 67104-86-3 (1E)-N-hydroxy-7-nitro-3,4-dihydronaphthalen-1(2H)-imine 

Downstream Products

• 939043-41-1 tert-butyl 8-amino-1,3,4,5-tetrahydro-2H-benzo[c]azepine-2-carboxylate 
• 223915-75-1 8-nitro-2,3,4,5-tetrahydro-1H-2-benzazepine 

Relevant articles and documents

HETEROARYL COMPOUNDS AND USES THEREOF

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same. It has now been found that compounds of this invention, and pharmaceutically acceptable compositions thereof, are effective as inhibitors of one or more protein kinases. Such compounds have general formula I or a pharmaceutically acceptable salt thereof, wherein Ring A, Ring B, W, Ry, R3 and R4 are as defined herein.

NEW COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6 MEDIATED DISORDERS SUCH AS ALZHEIMER'S DISEASE, COGNITIVE DISORDERS, COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA, OBESI

The present invention relates to new compounds of formula (I), or salts, solvates or solvated salts thereof, process for their preparation and to new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and